Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Not Yet Recruiting

Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

NCT03969693

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +19 more
Locations: Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Not Yet Recruiting

Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)

NCT05746858

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Istituto Nazionale Tumori Fondazione "G. Pascale" IRCCS Naples, Italy

Fonadazione Policlinico Universitario A. Gemelli Roma, Italy

Istituti Fisioterapici Ospitalieri -Istituto Regina Elena Roma, Italy

View Trial Details

Not Yet Recruiting

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

NCT02497898

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Completed

Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma

NCT03713580

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

NCT01087294

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

National Marrow Donor Program Minneapolis, Minnesota, United States

View Trial Details

Completed

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

NCT04975555

Conditions: Acute Lymphoblastic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +26 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Primary Bone Mature B-Cell NHL in Children

NCT07721194

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: CHU NICE Nice, Alpes Maritimes, France

View Trial Details

Completed

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

NCT03480360

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +33 more
Locations: Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

NCT05024045

Conditions: B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

City of Hope National Medical Center Duarte, California, United States

University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

View all 23 locations

View Trial Details

Completed

DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT05824585

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Research site New York, United States

Research site Albury, New South Wales, Australia

Research site Ballarat, Victoria, Australia

Research site Melbourne, Victoria, Australia

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions